Association of intermittent hydrarthrosis with MEFV gene mutations.
Cañete
Juan D
JD
Hospital Clínic, Barcelona, Spain.
Aróstegui
Juan I
JI
Queiró
Rubén
R
Sanmartí
Raimon
R
Ballina
Javier
J
Bosch
Xavier
X
Yagüe
Jordi
J
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003598:Cytoskeletal Proteins / Q000235:genetics* / Q000502:physiology; D004252:DNA Mutational Analysis; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D006833:Hydrarthrosis / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D008875:Middle Aged; D009154:Mutation; D010507:Periodicity; D000071198:Pyrin
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003598:Cytoskeletal Proteins; C000604192:MEFV protein, human; D000071198:Pyrin; D003078:Colchicine